Literature DB >> 19253312

Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.

Ji Hyae Lim1, Shin Young Kim, So Yeon Park, Moon Hee Lee, Jae Hyug Yang, Moon Young Kim, Jin Hoon Chung, Si Won Lee, Hyun Mee Ryu.   

Abstract

OBJECTIVE: This study aimed to analyze the differences of soluble endoglin (sEng) and transforming growth factor-beta1 (TGF-beta1) according to preeclamptic complications and to investigate the correlation between these factors and the clinical symptoms of preeclampsia.
METHOD: We estimated the levels of sEng and TGF-beta1 in plasma collected in the second trimester at the time of genetic amniocentesis from 60 women who subsequently developed preeclampsia and 124 contemporaneous normotensive women.
RESULTS: sEng levels were higher in cases than in controls, whereas TGF-beta1 levels were lower (P < 0.001). sEng levels, but not TGF-beta1 levels, were higher in cases with severe or preterm delivery than in cases with mild preeclampsia or term delivery (P < 0.001) and were increased in cases destined to deliver a small gestational age neonate (P < 0.001). Moreover, sEng levels, but not TGF-beta1 levels, showed a positive correlation with maximum diastolic and systolic blood pressure (r = 0.57, P < 0.001; and r = 0.33, P < 0.001, respectively) and proteinuria (r = 0.42, P < 0.001).
CONCLUSION: Early midtrimester plasma levels of sEng are predictive of subsequence occurrence and severity of preeclampsia, in terms of severity of hypertension and proteinuria, prematurity, and association with small for gestational age neonates. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19253312     DOI: 10.1002/pd.2217

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  11 in total

1.  Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips.

Authors:  Te-Yao Hsu; Jyun-Mu Lin; Mai-Huong T Nguyen; Feng-Hsiang Chung; Ching-Chang Tsai; Hsin-Hsin Cheng; Yun-Ju Lai; Hsuan-Ning Hung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2017-12-28       Impact factor: 5.911

2.  Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.

Authors:  Roberto Romero; Piya Chaemsaithong; Adi L Tarca; Steven J Korzeniewski; Eli Maymon; Percy Pacora; Bogdan Panaitescu; Noppadol Chaiyasit; Zhong Dong; Offer Erez; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-01

3.  Maternal and Cord Blood Plasma sEng and TGF-β1 in Patients with Hypertensive Disorders of Pregnancy: A Pilot Study in a South Indian Population.

Authors:  Vickneshwaran Vinayagam; Zachariah Bobby; Syed Habeebullah; Latha Chaturvedula; Shruthi K Bharadwaj
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 4.  Is inflammation the cause of pre-eclampsia?

Authors:  Wenda Ramma; Asif Ahmed
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

5.  Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity

Authors:  Pooneh Nikuei; Minoo Rajaei; Kianoosh Malekzadeh; Azim Nejatizadeh; Fatemeh Mohseni; Ali AtashAbParvar
Journal:  Iran Biomed J       Date:  2017-05-31

6.  Maternal serum endoglin as an early marker of pre-eclampsia in high-risk patients.

Authors:  Tarek M Elhawary; Aml S El-Bendary; Hala Demerdash
Journal:  Int J Womens Health       Date:  2012-09-26

7.  Response to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy.

Authors:  Karoline Mayer-Pickel; Sabine Horn; Uwe Lang; Mila Cervar-Zivkovic
Journal:  Case Rep Obstet Gynecol       Date:  2015-08-27

8.  Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia.

Authors:  Nalini Govender; Thajasvarie Naicker; Jagidesa Moodley
Journal:  Cardiovasc J Afr       Date:  2013-06       Impact factor: 1.167

Review 9.  Polymorphisms and plasma level of transforming growth factor-Beta 1 and risk for preeclampsia: a systematic review.

Authors:  Xun Li; Lin Shen; Hongzhuan Tan
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

10.  Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction.

Authors:  Dong Wook Kwak; Shin Young Kim; Hyun Jin Kim; Ji Hyae Lim; Young-Han Kim; Hyun Mee Ryu
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.